Cargando…
大剂量地塞米松联合小剂量利妥昔单抗作为二线方案治疗65例原发免疫性血小板减少症患者的临床观察
OBJECTIVE: To observe the efficacy of high-dose dexamethasone in combination with low-dose rituximab as a second-line treatment for patients with immune thrombocytopenia (ITP). METHODS: 65 patients with ITP, previously by conventional dose of glucocorticoids, received high-dose dexamethasone in comb...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342512/ https://www.ncbi.nlm.nih.gov/pubmed/25854463 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.03.007 |
Ejemplares similares
-
原发免疫性血小板减少症患者大剂量地塞米松治疗前后色氨酸代谢状态
Publicado: (2017) -
大剂量地塞米松治疗38例原发免疫性血小板减少症患儿的临床研究
Publicado: (2016) -
地塞米松、利妥昔单抗联合环磷酰胺治疗18例华氏巨球蛋白血症临床分析
Publicado: (2018) -
利妥昔单抗联合二线方案治疗七例复发难治性霍奇金淋巴瘤患者疗效观察
Publicado: (2015) -
大剂量地塞米松联合重组人血小板生成素治疗48例成人初治重症原发免疫性血小板减少症的有效性及安全性
Publicado: (2016)